EZH2, which is upregulated in MCL [101], and linked to adverse outcome [102], has been shown to bind a lncRNA termed ROR1-AS1, which increases cell proliferation in MCL cell lines; however, ROR1-AS1 expression was not significantly different when comparing MCL patients to normal controls [103]. Here, EZH2 is linked to mantle cell lymphoma.